IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 7666 
Small font sizeDefault font sizeIncrease font size
Read this article


    Article Cited by others


Zonisamide: A review of the clinical and experimental evidence for its use in Parkinson's disease

Grover Neeta D, Limaye Ramachandra P, Gokhale Dilip V, Patil Tatyasaheb R

Year : 2013| Volume: 45| Issue : 6 | Page no: 547-555

   This article has been cited by
1 Ion-Channel Antiepileptic Drugs: An Analytical Perspective on the Therapeutic Drug Monitoring (TDM) of Ezogabine, Lacosamide, and Zonisamide
Roberto Mandrioli, Michele Protti, Lorenzo Marincich, Laura Mercolini
Analytica. 2021; 2(4): 171
[Pubmed]  [Google Scholar] [DOI]
2 The safety of medications used to treat peripheral neuropathic pain, part 1 (antidepressants and antiepileptics): review of double-blind, placebo-controlled, randomized clinical trials
Marie Selvy, Mélissa Cuménal, Nicolas Kerckhove, Christine Courteix, Jérôme Busserolles, David Balayssac
Expert Opinion on Drug Safety. 2020; 19(6): 707
[Pubmed]  [Google Scholar] [DOI]
3 Zonisamide for the Treatment of Parkinson Disease: A Current Update
Chengqian Li, Li Xue, Yumei Liu, Zhengjie Yang, Song Chi, Anmu Xie
Frontiers in Neuroscience. 2020; 14
[Pubmed]  [Google Scholar] [DOI]
4 Zonisamide inhibits monoamine oxidase and enhances motor performance and social activity
Maiko T. Uemura, Takeshi Asano, Rie Hikawa, Hodaka Yamakado, Ryosuke Takahashi
Neuroscience Research. 2017; 124: 25
[Pubmed]  [Google Scholar] [DOI]
5 The agony of the agonists: a review of impulsivity and withdrawal syndromes in Parkinson's disease treatment
Andrea J Lindahl, Douglas G MacMahon
Future Neurology. 2015; 10(4): 357
[Pubmed]  [Google Scholar] [DOI]


Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow